Federal Court Finds Illumina Did Not Infringe Three Life Tech Patents | GenomeWeb

NEW YORK (GenomeWeb News) – A federal court judge has granted Illumina's motion for summary judgment that its sequencing technology does not infringe three Life Technologies patents.

In the decision handed down on Wednesday, Judge Cathy Ann Bencivengo of the US District Court for the Southern District of California said that Illumina does not infringe US Patent Nos. 5,616,478; 5,958,698; and 6,001,568 held by Life Technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."